Clinical trial

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

NCT03706833 · Edwards Lifesciences, Industry · Active, not recruiting

Key facts

NCT number NCT03706833
Title Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
Official title Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared…
Acronym CLASP IID/IIF
Lead sponsor Edwards Lifesciences, Industry
Status Active, not recruiting
Study type Interventional
Conditions Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
Intervention type Device
Interventions Edwards PASCAL System, Abbott Mitraclip System
Enrollment 1,247
Start date Nov 30, 2018
Primary completion Jun 30, 2026
Completion Jun 30, 2031
First posted Oct 16, 2018
Last update posted Jan 20, 2026
Countries Canada, Germany, Switzerland, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • 10–99 FDA inspections linked to this trial
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies